Hints and tips:
...After four years of joint development with Syneron, P&G’s business in Canada has started selling its Olay Professional ReFirme treatment for C$250 (US$248)....
...Syneron Medical shares lost 27.3 per cent to $27.05 by the close after the company's cellulite treatment was denied approval for marketing by US regulators....
International Edition